TC BioPharm (Holdings) plc Overview
TC BioPharm (Holdings) plc (TCBP) has a ROE of -794.56%, below the sector sector average of -4.03%.
Get informed when a big investor buys or sells
+ Follow-794.56%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
TC BioPharm (Holdings) plc (TCBP) currently reports a ROE of -794.56%. That is below the sector sector average of -4.03%. Use the charts on this page to explore TC BioPharm (Holdings) plc's ROE history and peer comparisons.
TC BioPharm (Holdings) plc's ROE of -794.56% is lower than the its sector sector average of -4.03%. That is roughly 19640.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but TC BioPharm (Holdings) plc's current -794.56% should be judged against industry norms (sector average: -4.03%) and against TCBP's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -794.56%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -4.03%. From there, open related valuation or income-statement pages for TC BioPharm (Holdings) plc, and consider following TCBP for alerts when major investors trade the stock.
